Filing Details
- Accession Number:
- 0001367644-20-000025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-06 16:37:46
- Reporting Period:
- 2020-03-04
- Accepted Time:
- 2020-03-06 16:37:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1193522 | W Louis Sullivan | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-04 | 7,893 | $13.00 | 68,359 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-04 | 7,893 | $58.96 | 60,466 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-03-04 | 7,893 | $14.71 | 68,359 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-04 | 7,893 | $58.96 | 60,466 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2020-03-04 | 7,893 | $14.71 | 7,893 | $14.71 |
| Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2020-03-04 | 7,893 | $13.00 | 7,893 | $13.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-05-20 | No | 4 | M | Direct | |
| 0 | 2020-05-23 | No | 4 | M | Direct |
Footnotes
- The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices at prices ranging from $58.75 to $59.14.
- Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated.
- The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.
Billionaire Hedge Funds
